ÂÜÀòÂÒÂ×

Trine Nilsen currently serves as the Assay Feasibility Team Lead at QuantuMDx Group Limited since May 2021, prior to which Trine held the position of Senior Scientist in the Microbiome division at Assembly Biosciences, Inc. from November 2019 to January 2021, and at Osel Inc. from January 2015 to November 2019. Trine's earlier roles include Scientist positions at the Norwegian Defence Research Establishment and Borregaard Industries Ltd., as well as a Research Scientist at Primera Biosystems. Trine's experience also includes a Staff Scientist II role at US Genomics and a Postdoctoral Research Fellow position at Harvard Medical School and Massachusetts General Hospital, focusing on protein targeting in Shigella flexneri. Trine's educational background includes a PhD in Biotechnology from the Norwegian University of Life Sciences and a Master of Science in Biotechnology from the Norwegian University of Science and Technology.